| REVIEW ARTICLE |
|
| Year : 2021 | Volume
: 10
| Issue : 4 | Page : 203-209 |
|
|
Hysteroscopy and retained products of conception: An update
Virginia Foreste1, Alessandra Gallo1, Alfonso Manzi1, Carla Riccardi2, Jose Carugno3, Attilio Di Spiezio Sardo2
1 Department of Neuroscience Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy
2 Department of Public Health, University of Naples Federico II, Naples, Italy
3 Department of Gynecology and Reproductive Sciences, Minimally Invasive Gynecology Division, University of Miami, Miller School of Medicine, Miami, Florida, USA
Correspondence Address:
Dr. Attilio Di Spiezio Sardo
University of Naples “Federico II”, Naples
Italy
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/GMIT.GMIT_125_20
|
|
|
Retained products of conception (RPOC) can occur after early or mid-trimester pregnancy termination and also following vaginal or cesarean delivery. It is frequently associated with continuous vaginal bleeding, pelvic pain, and infection. Late complications include intrauterine adhesions formation and infertility. Conventionally, the management of RPOC has been with blind dilation and suction curettage (D and C); however, hysteroscopic resection of RPOC is a safe and efficient alternative. In this review, we analyze the current available evidence regarding the use of hysteroscopic surgery for the treatment of RPOC comparing outcomes and complications of both traditional curettage and hysteroscopic technique. Data search has been conducted using the following databases MEDLINE, EMBASE, Web of Sciences, Scopus, Clinical Trial. Gov., OVID, and Cochrane Library interrogate all articles related to hysteroscopy and the preserved product of conception, updated through September 2020.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
